Ian T Clark
Disclosed holdings of Ian T Clark as of 2025-06-17: 9,851 shares of Guardant Health (GH), worth about $1.56M at the last close and 1 other company. From SEC…
What Ian T Clark reported holding
As of the latest filing on , Ian T Clark reported holding 9,851 shares of Guardant Health (GH), worth about $1.56M at the last close of $158 (Oct 19, 2026), held through a thornton-clark family trust, j thornton-clark & i clark tte account. Holdings are also on file at BioMarin Pharmaceutical (BMRN); together they are worth about $2.35M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Guardant Health GH | 9,851 | 9,851 thornton-clark family trust, j thornton-clark & i clark tte account | $158 | $1.56M | Jun 17, 2025 |
| BioMarin Pharmaceutical BMRN | 14,490 | 14K direct | $55 | $792K | Jun 2, 2026 |
Is this Ian T Clark’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Insider buying and selling since 2019
Ian T Clark has no open-market purchase on record since 2019. Sales in 5 of the 8 years since 2019.
Ian T Clark reported 0 open-market purchases and 46 sales since 2019; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | 1×1 trade |
| 2024 | — | 2×2 trades |
| 2021 | — | 7×7 trades |
| 2020 | — | 22×22 trades |
| 2019 | — | 14×14 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
The company behind these filings
- Guardant Health GH
Ian T Clark reported 0 open-market purchases and 46 sales here, 2019 to 2025.
- Market value
- $21.2B
- Last close
- $157.88
- 12 months
- +141.2%
- Against the S&P 500
- +125.8 pts
- Net margin
- -42.4%
- Revenue (last year)
- $982M
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Free account: get the written context of this page. Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Ian T Clark's trades
Has Ian T Clark bought shares on the open market?
Ian T Clark has no open-market purchase on record since 2019. Sales in 5 of the 8 years since 2019.
When did Ian T Clark last buy or sell shares?
In SEC filings since 2019: no open-market purchase is on record; the latest open-market sale is from 2025.
Which companies has Ian T Clark traded as an insider?
Guardant Health (GH), from 2019 to 2025: 0 purchases and 46 sales.